High-risk genomic consensus validation for patients with newly diagnosed multiple myeloma using next-generation sequencing.
Schavgoulidze A, Perrot A, Leleu X, Cazaubiel T, Chretien ML, Feugier P, Belhadj K, Manier S, Roussel M, Brechignac S, Orsini Piocelle F, Mohty M, Schiano de Colella JM, Macro M Dr, Adiko D, Dib M, Fontan J, Motard C, Bouscary D, Pascal L, Roland V, Lifermann F, Bakala JA, Montes L, Kennel C, Rey P, Richez V, Keddar F, Frenzel L, Calmettes C, Chaleteix C, Plantier I, Chalayer E, Schmitt A, Roul C, Demarquette H, Cerutti C, Pavageau L, Derrier L, Avet-Loiseau H, Corre J.
Schavgoulidze A, et al. Among authors: brechignac s.
Blood. 2025 Sep 24:blood.2025029999. doi: 10.1182/blood.2025029999. Online ahead of print.
Blood. 2025.
PMID: 40991836